Methods of making therapeutic polymeric material

US12350403B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12350403-B2
Application numberUS-201615774860-A
CountryUS
Kind codeB2
Filing dateNov 10, 2016
Priority dateNov 12, 2015
Publication dateJul 8, 2025
Grant dateJul 8, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Therapeutic polymeric materials, therapeutic polymeric materials containing medical implants and methods for making the same, and related materials are described. Methods of making medical implants containing additives/antibiotics, therapeutic polymers, and materials used therewith also are described. Methods of spatially controlling additive/antibiotic concentrations, non-homogenous distribution of therapeutic agents in polymeric materials and therapeutic medical implants containing layered constructs of polymeric materials are provided. Therapeutic medical implants containing incorporated therapeutic agents in the polymeric materials, for example, antibiotics into polymeric total joint implants, are useful for delivery of the therapeutic agents into the surrounding mediums.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt % to about 8 wt % gentamicin; c. layering the first UHMWPE blended with gentamicin with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 2. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt% to about 8 wt% gentamicin to form a first blended UHMWPE; c. layering the first blended UHMWPE with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 3. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene); b. blending the UHMWPE with about 6 wt % to about 8 wt % gentamicin to form the first blended UHMWPE; c. providing a second UHMWPE; d. blending the second UHMWPE with di-cumyl peroxide to form the second blended UHMWPE; e. layering the first and the second blended UHMWPEs to form a layered UHMWPEs; f. consolidating the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 4. The method according to claim 1 , wherein the first and the second UHMWPEs are pre-mixed with antioxidant. 5. The method according to claim 1 , wherein the antibiotic-eluting implantable medical device is a tibial insert. 6. The method according to claim 5 , wherein the tibial insert is packaged and sterilized. 7. A method of making a tibial insert comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt % to about 8 wt % gentamicin; c. layering the first UHMWPE blended with gentamicin with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the tibial insert, wherein the tibial insert is not permanent and removed after use, and wherein the implanted tibial insert elutes the antibiotic for at least 36 weeks. 8. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a UHMWPE (ultra-high molecular weight polyethylene); b. blending UHMWPE with about 6 wt % to about 8 wt % gentamicin; and c. direct compression molding the gentamicin-blended UHMWPE, thereby obtaining the antibiotic-eluting implantable device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks.

Assignees

Inventors

Classifications

  • for joint reconstruction · CPC title

  • Coatings comprising two or more layers · CPC title

  • Coatings containing a mixture of two or more compounds · CPC title

  • Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases · CPC title

  • Methods for coating medical devices · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12350403B2 cover?
Therapeutic polymeric materials, therapeutic polymeric materials containing medical implants and methods for making the same, and related materials are described. Methods of making medical implants containing additives/antibiotics, therapeutic polymers, and materials used therewith also are described. Methods of spatially controlling additive/antibiotic concentrations, non-homogenous distributi…
Who is the assignee on this patent?
Massachusetts Gen Hospital
What technology area does this patent fall under?
Primary CPC classification A61L27/54. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).